$697Million– No. of Holdings #74
| Ticker | $ Bought |
|---|---|
| corcept therapeutics inc | 27,199,500 |
| gsk plc | 21,296,700 |
| abbott laboratories | 19,155,600 |
| embecta corp | 16,335,000 |
| sionna therapeutics inc | 11,800,100 |
| monopar therapeutics inc | 9,506,390 |
| eyepoint inc | 9,303,810 |
| compass pathways plc | 8,331,080 |
| Ticker | % Inc. |
|---|---|
| cencora inc | 534 |
| abivax sa | 214 |
| vir biotechnology inc | 213 |
| ani pharmaceuticals inc | 204 |
| anteris technologies global | 187 |
| waystar hldg corp | 167 |
| icon plc | 140 |
| haemonetics corp mass | 138 |
| Ticker | % Reduced |
|---|---|
| zimmer biomet holdings inc | -83.76 |
| sanofi sa | -75.33 |
| organon & co | -74.69 |
| celcuity inc | -59.37 |
| neuroone med technologies co | -56.44 |
| hyperfine inc | -50.00 |
| context therapeutics inc | -31.58 |
| dianthus therapeutics inc | -22.01 |
| Ticker | $ Sold |
|---|---|
| xilio therapeutics inc | -1,366,530 |
| kenvue inc | -25,278,900 |
| ventyx biosciences inc | -3,501,390 |
| fulcrum therapeutics inc | -4,320,420 |
| brightspring health svcs inc | -11,535,000 |
| the cigna group | -47,395,400 |
| alkermes plc | -2,667,980 |
| ideaya biosciences inc | -2,617,990 |
Sio Capital Management, LLC has about 50.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 50.2 |
| Others | 42.7 |
| Industrials | 7.1 |
Sio Capital Management, LLC has about 9.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 38.1 |
| MID-CAP | 25 |
| SMALL-CAP | 20.5 |
| LARGE-CAP | 9.7 |
| MICRO-CAP | 5.6 |
About 45.1% of the stocks held by Sio Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 54.9 |
| RUSSELL 2000 | 39.9 |
| S&P 500 | 5.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Sio Capital Management, LLC has 74 stocks in it's portfolio. About 45.1% of the portfolio is in top 10 stocks. ICLR proved to be the most loss making stock for the portfolio. was the most profitable stock for Sio Capital Management, LLC last quarter.
Last Reported on: 14 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABC | cencora inc | 4.54 | 100,894 | 31,694,800 | added | 534 | ||
| ABT | abbott laboratories | 2.75 | 186,574 | 19,155,600 | new | |||
| ALGS | aligos therapeutics inc | 0.35 | 327,237 | 2,431,370 | reduced | -2.59 | ||
| ALKS | alkermes plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANIP | ani pharmaceuticals inc | 2.93 | 265,543 | 20,420,300 | added | 204 | ||
| ANTX | an2 therapeutics inc | 0.32 | 657,200 | 2,247,620 | new | |||
| AQST | aquestive therapeutics inc | 1.14 | 1,922,890 | 7,979,980 | added | 93.63 | ||
| AVTX | avalo therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 1.57 | 194,226 | 10,971,800 | reduced | -16.53 | ||
| CCRN | cross ctry healthcare inc | 1.48 | 1,098,390 | 10,324,900 | added | 2.77 | ||
| CELC | celcuity inc | 3.17 | 193,843 | 22,125,200 | reduced | -59.37 | ||
| CI | the cigna group | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMPS | compass pathways plc | 1.20 | 1,506,520 | 8,331,080 | new | |||
| CNTX | context therapeutics inc | 0.34 | 917,922 | 2,404,960 | reduced | -31.58 | ||
| CORT | corcept therapeutics inc | 3.90 | 674,759 | 27,199,500 | new | |||
| CRL | charles riv labs intl inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRNX | crinetics pharmaceuticals in | 1.30 | 249,887 | 9,075,900 | added | 100 | ||
| DRUG | bright minds biosciences inc | 0.90 | 86,083 | 6,281,480 | added | 5.13 | ||
| EMBC | embecta corp | 2.34 | 1,847,850 | 16,335,000 | new | |||
| ENTA | enanta pharmaceuticals inc | 0.07 | 40,000 | 505,200 | unchanged | 0.00 | ||